STOCK TITAN

Biofrontera: Rosalind securities face 9.99% cap

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Biofrontera Inc. (BFRI) is the issuer in an amended ownership report by Rosalind Master Fund L.P., its investment adviser Rosalind Advisors, Inc., and portfolio managers Steven Salamon and Gilad Aharon. The cover pages list 15,924,598 shares as each reporting person’s aggregate beneficial ownership and shared voting and dispositive power, including 1,789,288 common shares and 14,135,310 shares issuable upon exercise of preferred shares and convertible debt.

Item 4 says the Fund may have been deemed to beneficially own 1,789,288 common shares, approximately 9.96%. The 14,135,310 potentially issuable shares are subject to a 9.99% blocker, and the reporting persons could not exercise any of those securities as of September 30, 2026. The cover-page 9.9% figure is based on 17,949,000 common shares as of October 4, 2026. Rosalind Advisors and Steven Salamon disclaim beneficial ownership.

Reported aggregate beneficial ownership and shared voting/dispositive power 15,924,598 shares Listed for each reporting person on the cover pages; includes existing common shares and shares issuable upon exercise of preferred shares and convertible debt.
Common shares 1,789,288 shares Rosalind Master Fund may have been deemed to beneficially own these shares; Item 4 describes this as approximately 9.96% of common stock.
Shares issuable upon exercise 14,135,310 shares Shares issuable upon exercise of preferred shares and convertible debt; subject to blocker provisions.
Preferred-share conversion shares 11,089,618 shares Shares of common stock issuable upon exercise of preferred shares.
Convertible-debt shares 3,045,692 shares Shares of common stock issuable upon exercise of convertible debt.
Beneficial ownership blocker 9.99% Exercise is restricted to the extent it would result in the holder beneficially owning more than this percentage of common stock.
Common stock outstanding 17,949,000 shares As of October 4, 2026, as communicated by the issuer; basis stated for the cover-page percentage.
Cover-page ownership percentage 9.9% Percentage stated for each reporting person on the cover pages.
beneficial ownership regulatory
"may have been deemed to have the beneficial ownership of 1,789,288 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provision regulatory
"they contain a blocker provision under which the holder thereof does not have the right to exercise"
shared dispositive power regulatory
"Shared Dispositive Power 15,924,598.00"
convertible debt financial
"3,045,692 shares of Common Stock issuable upon exercise of convertible debt"
A convertible debt is a loan a company takes that gives the lender the option to swap the owed money for a set number of the company’s shares instead of getting cash back. It matters to investors because it can change who owns the company and how much their shares are worth: if lenders convert, existing shareholders can be diluted, but conversion can also signal confidence and reduce a company’s cash pressure — like getting a coupon that can be redeemed for store ownership rather than a refund.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BFRI shares did Rosalind Master Fund report owning?

The cover pages list 15,924,598 shares as aggregate beneficial ownership for each reporting person, while Item 4 says the Fund may have been deemed to beneficially own 1,789,288 common shares, approximately 9.96%. The larger figure includes 14,135,310 shares issuable upon exercise of preferred shares and convertible debt.

What limits Rosalind Master Fund’s ability to exercise BFRI securities?

A 9.99% blocker prevents exercise of preferred shares or convertible debt to the extent it would cause the holder’s beneficial ownership to exceed 9.99% of BFRI common stock. The reporting persons said they could not exercise any of those securities as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





09077D209

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 17,949,000 common stock as of October 4th, 2026, as communicated by the issuer. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 1,789,288 shares of Common Stock 11,089,618 shares of Common Stock issuable upon exercise of preferred shares 3,045,692 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,789,288 shares of Common Stock 11,089,618 shares of Common Stock issuable upon exercise of preferred shares 3,045,692 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,789,288 shares of Common Stock 11,089,618 shares of Common Stock issuable upon exercise of preferred shares 3,045,692 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,789,288 shares of Common Stock 11,089,618 shares of Common Stock issuable upon exercise of preferred shares 3,045,692 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:11/13/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:11/13/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:11/13/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:11/13/2026

Keep reading